{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:10Z","timestamp":1786120270454,"version":"build-2736575974"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/dcr.0b013e318223cb2b","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T20:17:22Z","timestamp":1317759442000},"page":"1326-1338","source":"Crossref","is-referenced-by-count":65,"title":["Treatment of Diverticular Disease of the Colon and Prevention of Acute Diverticulitis: A Systematic Review"],"prefix":"10.1097","volume":"54","author":[{"given":"Giovanni","family":"Maconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210119","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02049475","article-title":"Diverticulitis: a comprehensive follow-up.","volume":"39","author":"Munson","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"R2-19-20210119","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-5089(21)00097-3","article-title":"Natural history of diverticular disease of the colon.","volume":"4","author":"Parks","year":"1975","journal-title":"Clin Gastroenterol"},{"key":"R3-19-20210119","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM198002073020605","article-title":"Medical progress: diverticular disease of the colon.","volume":"302","author":"Almy","year":"1980","journal-title":"N Engl J Med"},{"key":"R4-19-20210119","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1056\/NEJMcp073228","article-title":"Clinical practice: diverticulitis.","volume":"357","author":"Jacobs","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-19-20210119","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/bega.2002.0297","article-title":"The pathology of diverticular disease.","volume":"16","author":"Ludeman","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R6-19-20210119","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2006.02896.x","article-title":"Review article: uncomplicated diverticular disease of the colon.","volume":"23","author":"Petruzziello","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-19-20210119","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0016-5085(88)90319-8","article-title":"Controlled treatment trials in the irritable bowel syndrome: a critique.","volume":"95","author":"Klein","year":"1988","journal-title":"Gastroenterology"},{"key":"R8-19-20210119","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0002-9343(99)00086-8","article-title":"Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials.","volume":"107","author":"Spiller","year":"1999","journal-title":"Am J Med"},{"key":"R9-19-20210119","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(77)92112-2","article-title":"Treatment of symptomatic diverticular disease with a high-fibre diet.","volume":"1","author":"Brodribb","year":"1977","journal-title":"Lancet"},{"key":"R10-19-20210119","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bmj.1.6005.315","article-title":"Sterculia bulk-forming agent with smooth-muscle relaxant versus bran in diverticular disease.","volume":"1","author":"Srivastava","year":"1976","journal-title":"Br Med J"},{"key":"R11-19-20210119","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.1.6016.988","article-title":"Bran tablets and diverticular disease.","volume":"1","author":"Taylor","year":"1976","journal-title":"Br Med J"},{"key":"R12-19-20210119","first-page":"157","article-title":"The placebo effect: is it important in diverticular disease?","volume":"67","author":"Hodgson","year":"1977","journal-title":"Am J Gastroenterol"},{"key":"R13-19-20210119","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.19.12.1144","article-title":"Comparison of bran, ispaghula, and lactulose on colon function in diverticular disease.","volume":"19","author":"Eastwood","year":"1978","journal-title":"Gut"},{"key":"R14-19-20210119","first-page":"49","article-title":"Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease.","volume":"500","author":"Ewerth","year":"1980","journal-title":"Acta Chir Scand Suppl"},{"key":"R15-19-20210119","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/bmj.282.6273.1353","article-title":"Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial.","volume":"282","author":"Ornstein","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R16-19-20210119","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1742-1241.1990.tb10835.x","article-title":"Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet.","volume":"44","author":"Smits","year":"1990","journal-title":"Br J Clin Pract"},{"key":"R17-19-20210119","first-page":"452","article-title":"Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon: a pilot multicentre open trial. Diverticular Disease Study Group.","volume":"24","author":"Papi","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"R18-19-20210119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.1995.tb00348.x","article-title":"Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon: a multicentre double-blind placebo-controlled trial.","volume":"9","author":"Papi","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-19-20210119","first-page":"157","article-title":"Efficacy of low dose mesalazine (5-ASA) in the treatment of acute inflammation and prevention of complications in patients with symptomatic diverticular disease: preliminary results [in Italian].","volume":"43","author":"Trespi","year":"1997","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R20-19-20210119","first-page":"245","article-title":"Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine: 4 year follow-up results [in Italian].","volume":"45","author":"Trepsi","year":"1999","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R21-19-20210119","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","article-title":"Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.","volume":"34","author":"Tursi","year":"2002","journal-title":"Dig Liver Dis"},{"key":"R22-19-20210119","first-page":"149","article-title":"Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension.","volume":"50","author":"Dughera","year":"2004","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R23-19-20210119","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10620-005-2478-z","article-title":"Efficacy of mesalazine in the treatment of symptomatic diverticular disease.","volume":"50","author":"Di Mario","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R24-19-20210119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.mcg.0000210092.77296.6d","article-title":"Mesalazine and\/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.","volume":"40","author":"Tursi","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R25-19-20210119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","article-title":"Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon.","volume":"18","author":"Latella","year":"2003","journal-title":"Int J Colorectal Dis"},{"key":"R26-19-20210119","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3748\/wjg.v13.i2.264","article-title":"Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease.","volume":"13","author":"Colecchia","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R27-19-20210119","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1007\/s10620-007-9766-8","article-title":"Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.","volume":"52","author":"Comparato","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R28-19-20210119","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000103896","article-title":"Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?","volume":"25","author":"Comparato","year":"2007","journal-title":"Dig Dis"},{"key":"R29-19-20210119","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00384-007-0299-6","article-title":"Balsalazide and\/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.","volume":"22","author":"Tursi","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"R30-19-20210119","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10620-006-9551-0","article-title":"Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon.","volume":"52","author":"Tursi","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R31-19-20210119","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2007.03266.x","article-title":"Interaction between rifaximin and dietary fibre in patients with diverticular disease.","volume":"25","author":"D'Inc\u00e0","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-19-20210119","first-page":"916","article-title":"Mesalazine and\/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon.","volume":"55","author":"Tursi","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"R33-19-20210119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.2.5806.137","article-title":"Unprocessed bran in treatment of diverticular disease of the colon.","volume":"2","author":"Painter","year":"1972","journal-title":"Br Med J"},{"key":"R34-19-20210119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.1.6007.425","article-title":"Diverticular disease: three studies. Part II. Treatment with bran.","volume":"1","author":"Brodribb","year":"1976","journal-title":"Br Med J"},{"key":"R35-19-20210119","first-page":"300","article-title":"The ambulatory medical treatment of colonic diverticulitis: an open clinico-endoscopic-histological study with rifaximin, a nonaminoglycoside enteric antibiotic [in Italian].","volume":"82","author":"Lombardo","year":"1991","journal-title":"Recenti Prog Med"},{"key":"R36-19-20210119","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/gut.33.3.352","article-title":"Does ispaghula husk stimulate the entire colon in diverticular disease?","volume":"33","author":"Thorburn","year":"1992","journal-title":"Gut"},{"key":"R37-19-20210119","first-page":"29","article-title":"Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon.","volume":"15","author":"Giaccari","year":"1993","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"R38-19-20210119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00042737-200303000-00015","article-title":"The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon.","volume":"15","author":"Fric","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R39-19-20210119","first-page":"I70","article-title":"Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.","volume":"10","author":"Brandimarte","year":"2004","journal-title":"Med Sci Monit"},{"key":"R40-19-20210119","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00042737-200309000-00011","article-title":"Patterns of pain in diverticular disease and the influence of acute diverticulitis.","volume":"15","author":"Simpson","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R41-19-20210119","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/bega.2002.0301","article-title":"Medical management of diverticular disease.","volume":"16","author":"Murray","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R42-19-20210119","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/MCG.0b013e318188adc1","article-title":"Emerging therapies for diverticular disease of the colon.","volume":"42","author":"Trivedi","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R43-19-20210119","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1440-1746.2007.05118.x","article-title":"Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence.","volume":"22","author":"Peppas","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R44-19-20210119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14656566.5.1.55","article-title":"Acute diverticulitis of the colon\u2014current medical therapeutic management.","volume":"5","author":"Tursi","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"7 suppl 3","key":"R45-19-20210119","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1097\/01.mcg.0000225509.98041.4b","article-title":"Use of mesalazine in diverticular disease.","volume":"40","author":"Di Mario","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R46-19-20210119","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/j.1572-0241.1999.01501.x","article-title":"Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology.","volume":"94","author":"Stollman","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R47-19-20210119","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1572-0241.2008.01879.x","article-title":"Diverticular disease and diverticulitis.","volume":"103","author":"Sheth","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R48-19-20210119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(04)15597-9","article-title":"Diverticular disease of the colon.","volume":"363","author":"Stollman","year":"2004","journal-title":"Lancet"},{"key":"R49-19-20210119","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejrad.2005.03.003","article-title":"CT in acute perforated sigmoid diverticulitis.","volume":"56","author":"Lohrmann","year":"2005","journal-title":"Eur J Radiol"},{"key":"R50-19-20210119","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2005.41154.x","article-title":"The management of complicated diverticulitis and the role of computed tomography.","volume":"100","author":"Kaiser","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R51-19-20210119","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/ajcn\/34.11.2460","article-title":"The effect of coarse and fine Canadian Red Spring Wheat and French Soft Wheat bran on colonic motility in patients with diverticular disease.","volume":"34","author":"Smith","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"R52-19-20210119","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.16.3.209","article-title":"The effect of wheat bran on intestinal transit.","volume":"16","author":"Payler","year":"1975","journal-title":"Gut"},{"key":"R53-19-20210119","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/bmj.4.5938.187","article-title":"Action of different bran preparations on colonic function.","volume":"4","author":"Kirwan","year":"1974","journal-title":"Br Med J"},{"key":"R54-19-20210119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bjs.1800670202","article-title":"Does a high fibre diet prevent the complications of diverticular disease?","volume":"67","author":"Hyland","year":"1980","journal-title":"Br J Surg"},{"key":"R55-19-20210119","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/pgmj.50.588.629","article-title":"The high fibre diet in the treatment of diverticular disease of the colon.","volume":"50","author":"Painter","year":"1974","journal-title":"Postgrad Med J"},{"key":"R56-19-20210119","first-page":"173","article-title":"High fibre diet in symptomatic diverticular disease of the colon.","volume":"67","author":"Leahy","year":"1985","journal-title":"Ann R Coll Surg Engl"},{"key":"R57-19-20210119","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/bmj.283.6305.1523","article-title":"Is bran useful in diverticular disease?","volume":"283","author":"Heaton","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R58-19-20210119","first-page":"681","article-title":"The role of dietary fibre in the prevention and treatment of diseases of the colon.","volume":"66","author":"Parks","year":"1973","journal-title":"Proc R Soc Med"},{"key":"R59-19-20210119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/1047-2797(94)00109-7","article-title":"A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men.","volume":"5","author":"Aldoori","year":"1995","journal-title":"Ann Epidemiol"},{"key":"R60-19-20210119","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ajcn\/60.5.757","article-title":"A prospective study of diet and the risk of symptomatic diverticular disease in men.","volume":"60","author":"Aldoori","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"R61-19-20210119","first-page":"1632","article-title":"Preventing diverticular disease: review of recent evidence on high-fibre diets.","volume":"48","author":"Aldoori","year":"2002","journal-title":"Can Fam Physician"},{"key":"R62-19-20210119","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","article-title":"A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.","volume":"101","author":"Sharara","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R63-19-20210119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation.","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"R64-19-20210119","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2036.2007.03313.x","article-title":"Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome.","volume":"25","author":"Frissora","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R65-19-20210119","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ajg.2009.621","article-title":"Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study.","volume":"105","author":"Jung","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R66-19-20210119","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF02234790","article-title":"Atypical diverticular disease: surgical results.","volume":"44","author":"Horgan","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R67-19-20210119","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J Exp Med"},{"issue":"suppl 1","key":"R68-19-20210119","first-page":"548","article-title":"Mesalamine alters colonic mucosal proteolytic activity and fecal bacterial profiles in diarrhea-predominant irritable bowel syndrome [abstract].","volume":"4","author":"Andrews","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-201110000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:20:24Z","timestamp":1786047624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003453-201110000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0b013e318223cb2b","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}